C-MYC pathway

No Pathway Network information available for C-MYC pathway

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

Disorders associated with C-MYC pathway SuperPath

according to GeneCards Suite gene sharing
#DisorderTypeGenesScore
1Precursor t-cell acute lymphoblastic leukemiaEnrichmentCDKN2A, MYC3.09
2TorticollisEnrichmentACTL6A2.73
3Caudal duplication anomalyEnrichmentAXIN12.73
4Knobloch syndrome 2EnrichmentPAK22.73
5Polydactyly-macrocephaly syndromeEnrichmentMAX2.73
6Deafness, autosomal dominant 75EnrichmentTRRAP2.73
7Developmental delay with or without dysmorphic facies and autismEnrichmentTRRAP2.73
8Craniometadiaphyseal osteosclerosis with hip dysplasiaEnrichmentAXIN12.73
9Developmental delay, hypotonia, and impaired languageEnrichmentFBXW72.73
10Cdkn2a cancer predispositionEnrichmentCDKN2A2.73
11Fischer-zirnsak progeroid syndromeEnrichmentSUPT7L2.73
12Melanoma-astrocytoma syndromeEnrichmentCDKN2A2.43
13Burkitt lymphomaEnrichmentMYC2.43
14Melanoma, cutaneous malignant 2EnrichmentCDKN2A2.43
15Neurodevelopmental disorder with dysmorphic facies, sleep disturbance, and brain abnormalitiesEnrichmentKAT52.43
16Immunodeficiency, common variable, 15EnrichmentRUVBL12.43
17Melanoma-pancreatic cancer syndromeEnrichmentCDKN2A2.43
18Houge-janssens syndrome 3EnrichmentPPP2CA2.43
19Cleidocranial dysplasia 1EnrichmentSUPT3H2.26
20Neurodevelopmental disorder with progressive spasticity and brain abnormalitiesEnrichmentRUVBL12.26
21Umbilical herniaEnrichmentACTL6A2.26
22High-grade b-cell lymphoma double-hit/triple-hitEnrichmentMYC2.26
23Cleidocranial dysplasiaEnrichmentSUPT3H2.26
24Knobloch syndromeEnrichmentPAK22.13
25Knobloch syndrome 1EnrichmentPAK22.04
26Pervasive developmental disorderEnrichmentFBXW72.04
27Rare pervasive developmental disorderEnrichmentFBXW72.04
28Li-fraumeni syndromeEnrichmentCDKN2A1.96
29Inguinal herniaEnrichmentACTL6A1.96
30Adrenocortical carcinomaEnrichmentCDKN2A1.96
31Lung squamous cell carcinomaEnrichmentCDKN2A1.96
32B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)EnrichmentCDKN2A1.89
33Gastroesophageal refluxEnrichmentACTL6A1.83
34Adult hepatocellular carcinomaEnrichmentAXIN11.78
35MelanomaEnrichmentCDKN2A1.74
36Leukemia, acute lymphoblasticEnrichmentCDKN2A1.70
37Atrial heart septal defectEnrichmentACTL6A1.70
38Interatrial communicationEnrichmentACTL6A1.70
39Complex neurodevelopmental disorderEnrichmentACTL6A, PPP2CA1.66
40Lip and oral cavity carcinomaEnrichmentCDKN2A1.66
41Acute promyelocytic leukemiaEnrichmentPML1.63
42Inherited cancer-predisposing syndromeEnrichmentCDKN2A, MAX1.61
43PheochromocytomaEnrichmentMAX1.59
44Melanoma, cutaneous malignant 1EnrichmentCDKN2A1.51
45Polycystic liver diseaseEnrichmentRUVBL11.51
46Autosomal dominant polycystic liver diseaseEnrichmentRUVBL11.51
47Hereditary paraganglioma-pheochromocytoma syndromesEnrichmentMAX1.42
48Hepatocellular carcinomaEnrichmentAXIN11.40
49Pancreatic cancerEnrichmentCDKN2A1.35
50Bladder cancerEnrichmentCDKN2A1.28
51Gastric cancerEnrichmentCDKN2A1.12
52Rare autosomal dominant non-syndromic sensorineural deafness type dfnaEnrichmentTRRAP1.04
53Colorectal cancerEnrichmentFBXW70.83
54Ovarian cancerEnrichmentCDKN2A0.77

Loading...
Loading...
Loading...